- News & Events
- Press Releases
- Meetings & Talks
- Travel Awards
Press Releases
February 22, 2010
Seahorse Bioscience, Inc. Secures $5 mil Growth Financing to Expand Worldwide Sales & Manufacturing Capacity
Seahorse Technology enhances drug discovery efforts in Cancer and Aging.
December 29, 2009
TheScientist Awards Seahorse XF96 Analyzer a Top Ten Innovation for 2009
XF Extracellular Flux Analyzer among the ten most exciting tools to impact the life sciences this year.
December 17, 2009
Seahorse Bioscience, Inc. Appoints Cell-Bio Biotechnology Co. Ltd Distributor in Taiwan
Asian Society for Mitochondrial Research Conference Highlights Taiwanese Researchers' Interest in Cellular Bioenergetics.
October 13, 2009
Seahorse Bioscience, Inc. Responds to Requests from Scientists in France, Appoints Proteigene Distributor
French Distributor to Enhance France's Access to Novel Technology.
September 9, 2009
Seahorse Bioscience to Present Novel Cellular Bioenergetics Data in Collaboration with University of Nebraska at AACR Metabolism and Cancer Conference
New instrument reveals the impact of genetic and nutrient factors in the malignant transformation of cancer cells.
May 29, 2009
New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the World's Leading Bioenergetics Researchers.
David Nicholls and Martin Brand collaborate with Seahorse Bioscience, Inc. to organize an advanced XF mitochondrial workshop and will share their years of experience studying promising disease pathways with workshop attendees.
March 12, 2009
Seahorse XF96 Extracellular Flux Analyzer wins Best New Product Award for DRUG DISCOVERY at 2009 Molecular Medicine Conference
First analytical instrument for the kinetic measure of mitochondrial oxygen consumption and cytoplasmic glycolysis...
March 9, 2009
Seahorse Bioscience, Inc. acquires BioProcessors Corp.
Market Vision, Engineering Know-how, and Smart Plastics Expertise Combine
to bring Practical Cell Technologies to the Life Sciences.
January 6, 2009
New! Seahorse now offering Travel Awards to Graduate Students and Post-docs...
To support the exploration of cellular bioenergetics, Seahorse Bioscience offers travel awards to Graduate Students and Post Doctoral researchers who present a talk or poster citing data generated on the XF platform at scientific meetings and conferences.
October 7, 2008
Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics
Seahorse Bioscience today announced the release of the first ever analytical instrument for the kinetic measurement of mitochondrial oxygen consumption and cytoplasmic glycolysis in cells in a 96 well microplate.
July 18, 2008
Seahorse Bioscience Receives Poster Award from The European Association for the Study of Obesity
Seahorse Bioscience, Inc., leaders in real-time measurement of cellular bioenergetics announced today the receipt of The European Association for the Study of Obesity (EASO) poster award at the 16th European Congress on Obesity (ECO 2008) May 14-17, 2008 in Geneva, Switzerland.
May 22, 2008
Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market
Seahorse Bioscience, leaders in real-time measurement of cellular bioenergetics, announced today that Primetech Corporation will become the exclusive supplier of Seahorse XF instruments and consumables in Japan.
January 17, 2008
Life Science Technologies Nano to Next Gen: Automation Gets Personal
Science Magazine
Seahorse Bioscience is automating an up-and-coming area of bioscience research: mitochondrial activity.
August 10, 2007
Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan To Board Of Directors
Seahorse Bioscience, the leading provider of tools for real-time measurement of cellular bioenergetics in microplates, announced today that former Molecular Devices executive Joseph Keegan has been appointed to the company's Board of Directors. In this position, Keegan will apply his successful business experience in the life sciences industry to accelerate the growth of Seahorse Bioscience's novel technology for profiling cell metabolism.